International immunopharmacology · 2026
β-Sitosterol attenuates gentamicin-induced nephrotoxicity via ADAM-17/ACE2/Ang 1-7/MasR Axis modulation in rats.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ewees Mohamed Gamal El-Din, Abdelzaher Lobna A, El-Shoura Ehab A M, Abdel Rahman Fatema El-Zahraa S, Shabaan Amany M, Embaby Marwa Ahmed, M Abdelmenem Alshaymaa, Ahmed Yasmin Moustafa
Аннотация
BACKGROUND: Gentamicin (Genta) is a widely used aminoglycoside antibiotic, but its clinical value is limited by nephrotoxicity involving oxidative stress, inflammation, apoptosis, and dysregulation of the ADAM-17/ACE2/Ang (1-7)/MasR axis. β-Sitosterol (BSST) is a phytosterol with reported antioxidant and anti-inflammatory properties, yet its nephroprotective activity and mechanistic link to this signaling pathway have not been explored. This study investigated whether BSST mitigates Genta-induced renal injury in association with modulation of this axis together with autophagy and apoptotic pathways.
METHODS: Male Wistar rats were assigned to five groups: control, BSST (40 mg/kg), Genta (100 mg/kg), and Genta combined with BSST (20 or 40 mg/kg). Renal function markers, oxidative stress indices, ELISA-based quantification of ADAM-17, ACE2, Ang (1-7), Ang II, and Cystatin-C, Western blot analyses of FOXO-1, LC3-II, P62, p38, and NF-κB, qRT-PCR for MasR, ATG5, TNF-α, and IL-6, histopathology, and caspase-3 immunostaining were performed.
RESULTS: Genta significantly increased serum creatinine, BUN, uric acid, Cystatin-C, renal MDA, ADAM-17, Ang II, NF-κB, and p38, while decreasing GSH, ACE2, Ang (1-7), LC3-II, ATG5, and MasR (P < 0.05). BSST co-treatment attenuated these alterations in a dose-dependent manner and markedly reduced renal apoptosis and tissue damage. The 40 mg/kg BSST dose produced the most pronounced effects.
CONCLUSION: This study provides novel evidence that BSST protects against Genta-induced nephrotoxicity with findings consistent with restoring the ADAM-17/ACE2/Ang (1-7)/MasR balance, suppressing oxidative and inflammatory responses, re-establishing autophagy, and reducing apoptosis. BSST may represent a promising nephroprotective adjunct during aminoglycoside therapy.
METHODS: Male Wistar rats were assigned to five groups: control, BSST (40 mg/kg), Genta (100 mg/kg), and Genta combined with BSST (20 or 40 mg/kg). Renal function markers, oxidative stress indices, ELISA-based quantification of ADAM-17, ACE2, Ang (1-7), Ang II, and Cystatin-C, Western blot analyses of FOXO-1, LC3-II, P62, p38, and NF-κB, qRT-PCR for MasR, ATG5, TNF-α, and IL-6, histopathology, and caspase-3 immunostaining were performed.
RESULTS: Genta significantly increased serum creatinine, BUN, uric acid, Cystatin-C, renal MDA, ADAM-17, Ang II, NF-κB, and p38, while decreasing GSH, ACE2, Ang (1-7), LC3-II, ATG5, and MasR (P < 0.05). BSST co-treatment attenuated these alterations in a dose-dependent manner and markedly reduced renal apoptosis and tissue damage. The 40 mg/kg BSST dose produced the most pronounced effects.
CONCLUSION: This study provides novel evidence that BSST protects against Genta-induced nephrotoxicity with findings consistent with restoring the ADAM-17/ACE2/Ang (1-7)/MasR balance, suppressing oxidative and inflammatory responses, re-establishing autophagy, and reducing apoptosis. BSST may represent a promising nephroprotective adjunct during aminoglycoside therapy.